TECTONIC THERAPEUTIC, INC. Operating Lease, Payments
TECTONIC THERAPEUTIC, INC. (TECX) had Operating Lease, Payments of $5.30 million as of 2025-09-30, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-26
- 2025-09-30: Operating Lease, Payments $5.30M.
- 2024-06-30: Operating Lease, Payments 6 month $765.00K.
- 2023-06-30: Operating Lease, Payments 6 month $489.00K.
| Period end | Operating Lease, Payments | Operating Lease, Payments 6 month |
|---|---|---|
| 2025-09-30 | $5.30M 10-K · filed 2026-02-26 | |
| 2024-06-30 | $765.00K 10-Q · filed 2024-08-14 | |
| 2023-06-30 | $489.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |